Active	Status	Sponsor type	Region	Phase	Filter
5 Active 2 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Fu, Shen
NCT05914142: Study on the Safety and Effectiveness of Varian ProBeam Proton Therapy Equipment in the Treatment of Solid Tumors	Completed	N/A	47	RoW	Proton radiation therapy	Guangzhou Concord Cancer Center, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Varian, a Siemens Healthineers Company	Solid Tumor, Radiation Therapy, Proton Therapy	07/23	07/23
Liu, Yimin
JADE, NCT06256588: A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma	Recruiting	3	864	Europe, Canada, Japan, US, RoW	Dostarlimab, Placebo	GlaxoSmithKline	Neoplasms, Head and Neck	05/28	07/29
NCT06338436: Varian ProBeam Proton Therapy System China Clinical Trial (Guangzhou)	Completed	N/A	47	RoW	Proton Radiation Therapy System (ProBeam)	Varian, a Siemens Healthineers Company	Tumor, Solid	09/23	11/23
NCT05914142: Study on the Safety and Effectiveness of Varian ProBeam Proton Therapy Equipment in the Treatment of Solid Tumors	Completed	N/A	47	RoW	Proton radiation therapy	Guangzhou Concord Cancer Center, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Varian, a Siemens Healthineers Company	Solid Tumor, Radiation Therapy, Proton Therapy	07/23	07/23